Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics, Susan G. Komen Partner on Breast Cancer Screening

NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.

San Diego-based Pathway will provide financial support and genetic testing for women in need at no charge, as part of the partnership, which follows a decision by the US Supreme Court two weeks ago that invalidated patents held by Myriad Genetics covering the BRCA1 and BRCA2 genes. The court, however, said that Myriad's methods applying knowledge about the genes are patentable.

Shortly after the SCOTUS decision, Pathway Genomics announced its plans to offer BRCA1/2 testing as part of its Hereditary Cancer DNA Insight test, which is scheduled to launch in August. As reported by Clinical Sequencing News, it is one of several companies, labs, and academic centers that have said that they will begin, or already have begun, offering BRCA testing.

"Providing patients with proper education and affordable hereditary cancer screening is extremely important to Pathway Genomics and will help pave the way to saving thousands of lives each year," company Founder and CEO Jim Plante said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.